Vitamin D Dosing for Elderly with Hypertension and Coronary Artery Disease
For elderly patients with hypertension and coronary artery disease, measure serum 25(OH)D levels first, then supplement to achieve and maintain levels above 30 ng/mL using 800-2000 IU daily of vitamin D3, with higher doses (up to 6000 IU daily) if initial levels are deficient. 1
Measurement First, Then Supplement
Since your patient has cardiovascular disease (hypertension and CAD), you should measure their baseline 25(OH)D level before starting supplementation 1. The guidelines specifically recommend testing for individuals with cardiovascular disease rather than empiric supplementation 1. This differs from healthy elderly individuals who can be supplemented without testing.
Target Serum Level
Aim for serum 25(OH)D levels above 30 ng/mL (75 nmol/L) 1. This threshold is specifically recommended for patients with cardiovascular disease and provides optimal benefits for cardiovascular health outcomes 1. The upper safety limit is 100 ng/mL, though no additional benefits are seen above 50 ng/mL 1.
Dosing Strategy
If 25(OH)D is Deficient (<30 ng/mL):
Start with a loading dose: 50,000 IU of vitamin D2 or D3 once weekly for 8 weeks 1, 2. This rapidly corrects deficiency.
Then maintenance: 1500-2000 IU daily (or equivalent intermittent dosing) 2. For elderly patients specifically, the 2024 Endocrine Society guideline suggests approximately 900 IU daily based on mortality benefit trials 3.
If 25(OH)D is Sufficient at Baseline:
Maintenance dosing: 800-2000 IU daily 1, 2. The rule of thumb: 1000 IU daily increases 25(OH)D by approximately 10 ng/mL 1.
Cardiovascular-Specific Considerations
The evidence for vitamin D and cardiovascular outcomes is nuanced:
Blood pressure effects: Meta-analyses show vitamin D supplementation significantly reduces systolic blood pressure in hypertensive patients with vitamin D deficiency, particularly with doses >400,000 IU cumulative over 8+ weeks 4. One trial showed 50,000 IU weekly for 8 weeks reduced systolic BP by 6.4 mmHg and diastolic by 2.4 mmHg 5.
CAD severity: Recent evidence suggests adequate vitamin D levels (≥30 ng/mL) are associated with lower coronary artery disease severity, partially mediated through HDL-C 6. Observational data consistently show 25(OH)D levels between 50-130 nmol/L (20-52 ng/mL) correlate with lowest cardiovascular mortality risk 7.
Mortality benefit: In adults ≥75 years, vitamin D supplementation (average ~900 IU daily) reduces all-cause mortality with a relative risk of 0.96 3. This is particularly relevant for your elderly patient.
Practical Implementation
Choose vitamin D3 (cholecalciferol) over D2 when available, as it maintains levels more reliably with intermittent dosing 1. Daily dosing is preferred over large annual doses—a single 500,000 IU annual dose showed adverse outcomes 1.
Recheck 25(OH)D levels at least 3 months after starting supplementation to ensure target is achieved 1. If levels remain insufficient, increase the maintenance dose—some patients may need 3000-6000 IU daily 2.
Monitor serum calcium periodically during high-dose supplementation, though hypercalcemia is rare below 10,000 IU daily and typically only occurs with doses >100,000 IU daily or 25(OH)D levels >100 ng/mL 1.
Common Pitfalls to Avoid
- Don't use calcitriol or other activated vitamin D forms to treat vitamin D deficiency—use ergocalciferol (D2) or cholecalciferol (D3) 8
- Don't skip baseline measurement in patients with established cardiovascular disease—the dosing strategy depends on knowing their starting level 1
- Don't use extremely high intermittent doses (like 500,000 IU annually)—stick to daily, weekly, or monthly regimens 1
- Don't forget that thiazide diuretics (commonly used for hypertension) can cause hypercalcemia when combined with vitamin D 9
The evidence strongly supports vitamin D supplementation in this population for both cardiovascular benefits and mortality reduction, but the approach must be individualized based on measured 25(OH)D levels rather than using a one-size-fits-all dose.